4 results  1 of 1 

1 Comparison of Serum Ketone Levels and Cardiometabolic Efficacy of Dapagliflozin versus Sitagliptin among Insulin-Treated Chinese Patients with Type 2 Diabetes Mellitus
Chi-Ho Lee, Mei-Zhen Wu, David Tak-Wai Lui, Darren Shing-Hei Chan, Carol Ho-Yi Fong, Sammy Wing-Ming Shiu, Ying Wong, Alan Chun-Hong Lee, Joanne King-Yan Lam, Yu-Cho Woo, Karen Siu-Ling Lam, Kelvin Kai-Hang Yiu, Kathryn Choon-Beng Tan
Diabetes Metab J.2022;46(6):843-854.   Published online 2022 April 28     DOI: http://dx.doi.org/10.4093/dmj.2021.0319
      
2 Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea
Yujin Shin, Ji Hye Moon, Ho Jun Chin, Ele Ferrannini, Soo Lim
Endocrinol Metab.2020;35(2):329-338.   Published online 2020 June 30     DOI: http://dx.doi.org/10.3803/EnM.2020.35.2.329
      
3 The Potential Cardioprotective Mechanism of Sodium-Glucose Cotransporter 2 Inhibitors
Jae-Han Jeon
J Korean Diabetes.2019;20(2):81-86.   Published online 2019 June 30     DOI: http://dx.doi.org/10.4093/jkd.2019.20.2.81
      
4 In-depth Medical Nutrition Therapy for a Woman with Diabetes: From Pregnancy to Delivery
Miyoung Jang, Dal Lae Ju, MeeRa Kweon, Misun Park
Clin Nutr Res.2016;5(4):305-309.   Published online 2016 October 31     DOI: http://dx.doi.org/10.7762/cnr.2016.5.4.305
      

 1 of 1